Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Innovent's Tepezza rival closer to China nod after phase 3 win
Innovent hopes the win will give it a first shot at the Chinese equivalent of a market that has already been conquered by Amgen’s Tepezza in the U.S.
James Waldron
Feb 20, 2024 8:38am
I-Mab sheds China footprint to transform into US-based biotech
Feb 7, 2024 8:50am
Arrivent unveils $135M IPO pricing to get furmonertinib to FDA
Jan 22, 2024 10:28am
Windtree hands over more licensing rights to Lee’s Pharma
Jan 17, 2024 9:29am
JPM24: Roche's pharma BD chief explains renewed ADC interest
Jan 12, 2024 10:56am
Flagship CEO says firm has work to do before inking China pacts
Jan 8, 2024 9:05pm